| Literature DB >> 10390240 |
A Watanabe1, Y Tokue, H Takahashi, T Kikuchi, T Kobayashi, K Gomi, S Fujimura, T Nukiwa.
Abstract
The in vitro activity of HSR-903, an oral quinolone, against 196 recent clinical isolates of respiratory pathogens was evaluated. HSR-903 was 2 to 32 times more active than ofloxacin, ciprofloxacin, and sparfloxacin against Staphylococcus aureus, including methicillin-resistant strains, and Streptococcus pneumoniae and was at least as active as the other quinolones against gram-negative pathogens.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10390240 PMCID： PMC89361
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191